NIMG-36. EVALUATION OF [18F]DASA-23 FOR NON-INVASIVE MEASUREMENT OF ABERRANTLY EXPRESSED PYRUVATE KINASE M2 IN GLIOMA: FIRST-IN-HUMAN STUDY

OBJECTIVES: We developed 1-((2-fluoro-6-(fluoro-[18F])phenyl)sulfonyl)-4-((4-methoxyphenyl)sulfonyl)piperazine ([18F]DASA-23) as a novel radiopharmaceutical to measure pyruvate kinase M2 levels by positron emission tomography (PET). PKM2 catalyzes the final step in glycolysis, the key process of tum...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Patel, Chirag, Beinat, Corinne, Haywood, Tom, Murty, Surya, Xie, Yuanyang, Recht, Lawrence, Nagpal, Seema, Thomas, Reena, Khalighi, Mohammad, Gandhi, Harsh, Holley, Dawn, Gambhir, Sanjiv
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Neuro-Imaging
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847186/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.706
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires